20 LATEST RESOURCES (1964 INDEXED)
×
Hallucinogenic Potential: A Review of Psychoplastogens for the Treatment of Opioid Use Disorder · August 2023
Articles
Frontiers in Pharmacology
×
Association between Body Mass Index and Treatment Completion in Extended-Release Naltrexone-Treated Patients with Opioid Dependence · August 2023
Articles
Frontiers in Psychiatry
×
Genetics of Cannabis Use in Opioid Use Disorder: A Genome-Wide Association and Polygenic Risk Score Study · July 2023
Articles
PLOS ONE
×
Implementing Buprenorphine Prolonged-Release Injection Using a Health at the Margins Approach for Transactional Sex-Workers · July 2023
Articles
Frontiers in Psychiatry
×
Provision of Digital Health Technologies for Opioid Use Disorder Treatment by US Health Care Organizations · July 2023
Articles
JAMA Network Open
×
The Motives and Methods of Methamphetamine and ‘Heroin’ Co-Use in West Virginia · July 2023
Articles
Harm Reduction Journal
×
Trends in Rates of Opioid Agonist Treatment and Opioid-Related Deaths for Youths in Ontario, Canada, 2013-2021 · July 2023
Articles
JAMA Network Open
×
Naloxone Accessibility Under the State Standing Order Across Mississippi · July 2023
Articles
JAMA Network Open
×
Examination of the Accuracy of Existing Overdose Surveillance Systems · June 2023
Articles
JAMA Network Open
×
Depression and Suicidal Ideation among Patients Receiving Opioid Maintenance Treatments Considering Cognitive Flexibility · June 2023
Articles
Iranian Journal of Psychiatry
×
“I Wouldn’t Need Narcan for Myself, But I Can Have It for Somebody Else:” Perceptions of Harm Reduction among Hospitalized Patients with OUD · June 2023
Articles
Addiction Science and Clinical Practice
×
Nurse Prescribing Practices Across the Globe for Medication-Assisted Treatment of the Opioid Use Disorder (MOUD): A Scoping Review · June 2023
Articles
Harm Reduction Journal
×
Patients’ Goals When Initiating Long-Acting Injectable Buprenorphine Treatment for Opioid Use Disorder: Findings from a Longitudinal Qualitative Study · June 2023
Articles
Substance Abuse Treatment, Prevention, and Policy
×
Long-Term Deprescription in Chronic Pain and Opioid Use Disorder Patients: Pharmacogenetic and Sex Differences · June 2023
Articles
Acta Pharmaceutica
×
Associations of Methadone and Buprenorphine-Naloxone Doses with Unregulated Opioid Use, Treatment Retention, and Adverse Events in Prescription-Type Opioid Use Disorders: Exploratory Analyses of the OPTIMA Study · June 2023
Articles
American Journal on Addictions
×
The Four-Factor Personality Model and Its Qualitative Correlates among Opioid Agonist Therapy Clients · June 2023
Articles
Frontiers in Psychiatry
×
Medical Marijuana Access and Prolonged Opioid Use among Adolescents and Young Adults · June 2023
Articles
American Journal on Addictions
×
Informing Youth-Centred Opioid Agonist Treatment: Findings from a Retrospective Chart Review of Youths’ Characteristics and Patterns of Opioid Agonist Treatment Engagement in a Novel Integrated Youth Services Program · May 2023
Articles
Early Intervention in Psychiatry
×
Naloxone Training and Availability in the US Commercial Fishing Industry · May 2023
Articles
American Journal of Industrial Medicine